Edward E Schmidt Selected Research

Edward E Schmidt Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 03/2014
2	Hyperoxia 01/2021 - 11/2012
2	Inflammation (Inflammations) 11/2019 - 01/2018
2	Fibrosis (Cirrhosis) 11/2019 - 01/2018
2	Infections 01/2016 - 01/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2021
1	COVID-19 01/2021
1	Cardiotoxicity 01/2020
1	Cholestasis 11/2019
1	Liver Diseases (Liver Disease) 11/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Fatty Liver 01/2018
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Adenocarcinoma of Lung 11/2017
1	Carcinogenesis 08/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2016
1	Superinfection 01/2016
1	Necrotizing Pneumonia 01/2016
1	Empyema 01/2016
1	Necrosis 03/2015
1	Breast Neoplasms (Breast Cancer) 03/2014
1	Lung Injury 11/2012
1	Spontaneous Abortion (Miscarriage) 10/2008
1	Spinocerebellar Ataxia 17 09/2007
1	Disease Progression 09/2007
1	Huntington Disease (Huntington's Disease) 09/2007
1	X-Linked Bulbo-Spinal Atrophy 09/2007
1	Tetraploidy 07/2002

Drug/Important Bio-Agent (IBA)

5	AntioxidantsIBA 02/2021 - 08/2016
4	Glutathione (Reduced Glutathione)IBA 02/2021 - 11/2012
3	Proteins (Proteins, Gene)FDA Link 11/2019 - 09/2007
2	Oxygen (Dioxygen)IBA 01/2021 - 11/2012
2	C.I. direct red 80IBA 11/2019 - 01/2018
2	AldehydesIBA 11/2019 - 01/2018
2	tributyl phosphate (TBP)IBA 09/2007 - 07/2002
1	Heme Oxygenase-1IBA 01/2021
1	4- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamideIBA 01/2021
1	Superoxide Dismutase-1IBA 01/2021
1	Actins (F Actin)IBA 01/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	EnzymesIBA 01/2020
1	adriamycinolIBA 01/2020
1	Liver ExtractsIBA 11/2019
1	Acrolein (Aqualin)IBA 11/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	ThioredoxinsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 01/2019
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2019
1	CollagenIBA 01/2018
1	GlycogenIBA 01/2018
1	TensinsIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 11/2017
1	Kelch-Like ECH-Associated Protein 1IBA 11/2017
1	GlutaminaseIBA 11/2017
1	sulforaphaneIBA 08/2016
1	isothiocyanic acidIBA 08/2016
1	ErbB Receptors (EGF Receptor)IBA 08/2016
1	Interferon Type IIBA 01/2016
1	Interleukin-13IBA 01/2016
1	Blocking AntibodiesIBA 01/2016
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	Methionine (L-Methionine)FDA Link 03/2015
1	LyasesIBA 03/2015
1	NADP (NADPH)IBA 03/2015
1	Cysteine (L-Cysteine)FDA Link 03/2015
1	CystathionineIBA 03/2015
1	NF-E2-Related Factor 2IBA 11/2012
1	Thioredoxin-Disulfide ReductaseIBA 11/2012
1	Oxidants (Oxidizing Agents)IBA 11/2012
1	Aurothioglucose (Gold 50)IBA 11/2012
1	Messenger RNA (mRNA)IBA 01/2010
1	Isoantigens (Alloantigen)IBA 10/2008
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 09/2007
1	Huntingtin ProteinIBA 09/2007
1	Androgen Receptors (Androgen Receptor)IBA 09/2007
1	polyglutamineIBA 09/2007

Therapy/Procedure

3	Therapeutics 10/2021 - 08/2016
1	Chemoprevention 08/2016
1	Ovariectomy (Oophorectomy) 03/2014